As the global economy continues to recover from the most challenging economic period in decades, business execution is consistently mentioned by executives as a top priority. Biopharmaceutical and healthcare companies have endured tremendous change, undertaking dramatic cost cutting initiatives designed to right-size industry players to a new, highly competitive market environment. Now leaders are focused on improving their organizations’ ability to execute. As they shift attention to growth and achieving their companies’ long-term innovation and customer-focused strategies, biopharmaceutical executives are looking for frameworks to evaluate and address gaps in their organizations’ strategic capabilities – the unique set of people, processes and technology that creates competitive advantage in the marketplace.

BRG's strategic capability offering provides organizations with a comprehensive, holistic and proven framework for identifying the people, process and technology enablers of customer and financial imperatives. By facilitating a robust dialogue, supported by analysis and insights, BRG helps leaders build consensus on how their strategic capabilities will drive results and create value. The framework is also designed to support existing strategic HR programs, such as workforce planning, organizational and leadership alignment, and talent management.

Back to Representative Engagements